aspsirna1013 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna1013
siRNA Name: siRNAT2
Gene:Collagen type I alpha 1 (COL1A1)
Disease:Osteogenesis Imperfecta (OI)
Wild allele/target (5'->3'): CCCCAAAAGCCAAAAAAUG
Mutant allele/target (5'->3'):CCUCAAAAGCCAAAAAAUG
Target Mutation: c.*88T>C
Wild siRNA (As strand):GGGGUUUUCGGUUUUUUAC
ASP-siRNA (As strand):GGAGUUUUCGGUUUUUUAC
Mismatch position in siRNA: A17G
Mutant allele (5'->3'): CCUCAAAAGCCAAAAAAUG
ASP-siRNA (As strand):GGAGUUUUCGGUUUUUUAC
ASP-siRNA efficacy for mutant allele:78
Wild allele (5'->3'): CCCCAAAAGCCAAAAAAUG
ASP-siRNA (As strand):GGAGUUUUCGGUUUUUUAC
ASP-siRNA efficacy for wild allele:44
Percentage discrimination for ASP-siRNA:34
Wild allele (5'->3'): CCCCAAAAGCCAAAAAAUG
Wild siRNA (As strand):GGGGUUUUCGGUUUUUUAC
Wild sirna efficacy for wild allele:NA
Wild allele (5'->3'): CCCCAAAAGCCAAAAAAUG
ASP-siRNA (As strand):GGAGUUUUCGGUUUUUUAC
Wild sirna efficacy for mutant allele:NA
Percentage discrimination for wild siRNA:NA
Concentration:50nMol
Orientation:Double strand
Mismatch in:siRNA
UniProt ID: P02452
Target sequence: CCCCTCAAAAGCCAAAAAATG
Genbank Accesion: NM_000088.3
Cell-line: Cos-7
Experimental technique used: ELISA assay
Transfection method: Lipofectamine 2000
siRNA expression method: Qiagen
Post-transfection duration: 24 hours
OMID ID: 166210
KEGG disease ID:H00506
Reference:15241481

.
.
.
.
.
.
.
.
.
.
.

.

.

.